Tecovirimat for the Treatment of Human Monkeypox: An Initial Series From Massachusetts, United States

Abstract A large, ongoing multicountry outbreak of human monkeypox has the potential to cause considerable morbidity and mortality. Therapeutics for the treatment of smallpox, a related Orthopoxvirus, may be used and affect the natural history of monkeypox. We present 3 patients from our hospitals t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Open Forum Infectious Diseases 2022-08, Vol.9 (8), p.ofac377-ofac377
Hauptverfasser: Matias, Wilfredo R, Koshy, Jacob M, Nagami, Ellen H, Kovac, Victor, Moeng, Letumile R, Shenoy, Erica S, Hooper, David C, Madoff, Lawrence C, Barshak, Miriam B, Johnson, Jennifer A, Rowley, Christopher F, Julg, Boris, Hohmann, Elizabeth L, Lazarus, Jacob E
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page ofac377
container_issue 8
container_start_page ofac377
container_title Open Forum Infectious Diseases
container_volume 9
creator Matias, Wilfredo R
Koshy, Jacob M
Nagami, Ellen H
Kovac, Victor
Moeng, Letumile R
Shenoy, Erica S
Hooper, David C
Madoff, Lawrence C
Barshak, Miriam B
Johnson, Jennifer A
Rowley, Christopher F
Julg, Boris
Hohmann, Elizabeth L
Lazarus, Jacob E
description Abstract A large, ongoing multicountry outbreak of human monkeypox has the potential to cause considerable morbidity and mortality. Therapeutics for the treatment of smallpox, a related Orthopoxvirus, may be used and affect the natural history of monkeypox. We present 3 patients from our hospitals treated with tecovirimat, a pan-Orthopoxvirus inhibitor currently available under an expanded access investigational new drug protocol for monkeypox.
doi_str_mv 10.1093/ofid/ofac377
format Article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9356679</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A776147225</galeid><oup_id>10.1093/ofid/ofac377</oup_id><sourcerecordid>A776147225</sourcerecordid><originalsourceid>FETCH-LOGICAL-c549t-ecd6dca327be09969c09c582f479a5d579b20d401ef53dc7a06f9a9e572531a93</originalsourceid><addsrcrecordid>eNp9kc1rXCEUxaW0NGGaXdfFXbvIpH48n2MXhSE0TSChi0zW4ug1Y_ueTtUXkv--DjMN6aYIV_H-7uEeDkLvKTmjRPHPyQfXirFcylfomHG2mC-UkK9fvI_QSSk_CSGUEkGkeouOuFCd6gg_RrACmx5CDqOp2KeM6wbwKoOpI8SKk8eX02givknxFzxt0-MXvIz4KoYazIBvIQco-CKnEd-YUozdTAVqLaf4riHg8G01Fco79MabocDJ4Z6hu4tvq_PL-fWP71fny-u5FZ2qc7Cud9ZwJtdAlOqVJcqKBfOdVEY4IdWaEdcRCl5wZ6UhvVdGgZBMcGoUn6Gve93ttB7B2WYhm0Fvd_byk04m6H87MWz0fXrQiou-lzuBTweBnH5PUKoeQ7EwDCZCmopmklAiO9qzhp7t0XszgA7Rp6Zo23EwBpsi-ND-l1L2tJOsLThDp_sBm1MpGfzzXpToXZp6l6Y-pNnwDy-9PMN_s2vAxz2Qpu3_pf4AuVarHQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2701074162</pqid></control><display><type>article</type><title>Tecovirimat for the Treatment of Human Monkeypox: An Initial Series From Massachusetts, United States</title><source>Oxford Journals Open Access Collection</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Matias, Wilfredo R ; Koshy, Jacob M ; Nagami, Ellen H ; Kovac, Victor ; Moeng, Letumile R ; Shenoy, Erica S ; Hooper, David C ; Madoff, Lawrence C ; Barshak, Miriam B ; Johnson, Jennifer A ; Rowley, Christopher F ; Julg, Boris ; Hohmann, Elizabeth L ; Lazarus, Jacob E</creator><creatorcontrib>Matias, Wilfredo R ; Koshy, Jacob M ; Nagami, Ellen H ; Kovac, Victor ; Moeng, Letumile R ; Shenoy, Erica S ; Hooper, David C ; Madoff, Lawrence C ; Barshak, Miriam B ; Johnson, Jennifer A ; Rowley, Christopher F ; Julg, Boris ; Hohmann, Elizabeth L ; Lazarus, Jacob E</creatorcontrib><description>Abstract A large, ongoing multicountry outbreak of human monkeypox has the potential to cause considerable morbidity and mortality. Therapeutics for the treatment of smallpox, a related Orthopoxvirus, may be used and affect the natural history of monkeypox. We present 3 patients from our hospitals treated with tecovirimat, a pan-Orthopoxvirus inhibitor currently available under an expanded access investigational new drug protocol for monkeypox.</description><identifier>ISSN: 2328-8957</identifier><identifier>EISSN: 2328-8957</identifier><identifier>DOI: 10.1093/ofid/ofac377</identifier><identifier>PMID: 35949403</identifier><language>eng</language><publisher>United States: Oxford University Press</publisher><subject>Brief Report ; Care and treatment ; Health aspects ; Hospitals ; Human monkeypox ; Massachusetts ; Smallpox vaccine</subject><ispartof>Open Forum Infectious Diseases, 2022-08, Vol.9 (8), p.ofac377-ofac377</ispartof><rights>The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America. 2022</rights><rights>The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America.</rights><rights>COPYRIGHT 2022 Oxford University Press</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c549t-ecd6dca327be09969c09c582f479a5d579b20d401ef53dc7a06f9a9e572531a93</citedby><cites>FETCH-LOGICAL-c549t-ecd6dca327be09969c09c582f479a5d579b20d401ef53dc7a06f9a9e572531a93</cites><orcidid>0000-0001-8086-1123 ; 0000-0002-4687-9626 ; 0000-0001-9286-3548</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356679/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356679/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,1598,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35949403$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Matias, Wilfredo R</creatorcontrib><creatorcontrib>Koshy, Jacob M</creatorcontrib><creatorcontrib>Nagami, Ellen H</creatorcontrib><creatorcontrib>Kovac, Victor</creatorcontrib><creatorcontrib>Moeng, Letumile R</creatorcontrib><creatorcontrib>Shenoy, Erica S</creatorcontrib><creatorcontrib>Hooper, David C</creatorcontrib><creatorcontrib>Madoff, Lawrence C</creatorcontrib><creatorcontrib>Barshak, Miriam B</creatorcontrib><creatorcontrib>Johnson, Jennifer A</creatorcontrib><creatorcontrib>Rowley, Christopher F</creatorcontrib><creatorcontrib>Julg, Boris</creatorcontrib><creatorcontrib>Hohmann, Elizabeth L</creatorcontrib><creatorcontrib>Lazarus, Jacob E</creatorcontrib><title>Tecovirimat for the Treatment of Human Monkeypox: An Initial Series From Massachusetts, United States</title><title>Open Forum Infectious Diseases</title><addtitle>Open Forum Infect Dis</addtitle><description>Abstract A large, ongoing multicountry outbreak of human monkeypox has the potential to cause considerable morbidity and mortality. Therapeutics for the treatment of smallpox, a related Orthopoxvirus, may be used and affect the natural history of monkeypox. We present 3 patients from our hospitals treated with tecovirimat, a pan-Orthopoxvirus inhibitor currently available under an expanded access investigational new drug protocol for monkeypox.</description><subject>Brief Report</subject><subject>Care and treatment</subject><subject>Health aspects</subject><subject>Hospitals</subject><subject>Human monkeypox</subject><subject>Massachusetts</subject><subject>Smallpox vaccine</subject><issn>2328-8957</issn><issn>2328-8957</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>TOX</sourceid><recordid>eNp9kc1rXCEUxaW0NGGaXdfFXbvIpH48n2MXhSE0TSChi0zW4ug1Y_ueTtUXkv--DjMN6aYIV_H-7uEeDkLvKTmjRPHPyQfXirFcylfomHG2mC-UkK9fvI_QSSk_CSGUEkGkeouOuFCd6gg_RrACmx5CDqOp2KeM6wbwKoOpI8SKk8eX02givknxFzxt0-MXvIz4KoYazIBvIQco-CKnEd-YUozdTAVqLaf4riHg8G01Fco79MabocDJ4Z6hu4tvq_PL-fWP71fny-u5FZ2qc7Cud9ZwJtdAlOqVJcqKBfOdVEY4IdWaEdcRCl5wZ6UhvVdGgZBMcGoUn6Gve93ttB7B2WYhm0Fvd_byk04m6H87MWz0fXrQiou-lzuBTweBnH5PUKoeQ7EwDCZCmopmklAiO9qzhp7t0XszgA7Rp6Zo23EwBpsi-ND-l1L2tJOsLThDp_sBm1MpGfzzXpToXZp6l6Y-pNnwDy-9PMN_s2vAxz2Qpu3_pf4AuVarHQ</recordid><startdate>20220801</startdate><enddate>20220801</enddate><creator>Matias, Wilfredo R</creator><creator>Koshy, Jacob M</creator><creator>Nagami, Ellen H</creator><creator>Kovac, Victor</creator><creator>Moeng, Letumile R</creator><creator>Shenoy, Erica S</creator><creator>Hooper, David C</creator><creator>Madoff, Lawrence C</creator><creator>Barshak, Miriam B</creator><creator>Johnson, Jennifer A</creator><creator>Rowley, Christopher F</creator><creator>Julg, Boris</creator><creator>Hohmann, Elizabeth L</creator><creator>Lazarus, Jacob E</creator><general>Oxford University Press</general><scope>TOX</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IAO</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-8086-1123</orcidid><orcidid>https://orcid.org/0000-0002-4687-9626</orcidid><orcidid>https://orcid.org/0000-0001-9286-3548</orcidid></search><sort><creationdate>20220801</creationdate><title>Tecovirimat for the Treatment of Human Monkeypox: An Initial Series From Massachusetts, United States</title><author>Matias, Wilfredo R ; Koshy, Jacob M ; Nagami, Ellen H ; Kovac, Victor ; Moeng, Letumile R ; Shenoy, Erica S ; Hooper, David C ; Madoff, Lawrence C ; Barshak, Miriam B ; Johnson, Jennifer A ; Rowley, Christopher F ; Julg, Boris ; Hohmann, Elizabeth L ; Lazarus, Jacob E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c549t-ecd6dca327be09969c09c582f479a5d579b20d401ef53dc7a06f9a9e572531a93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Brief Report</topic><topic>Care and treatment</topic><topic>Health aspects</topic><topic>Hospitals</topic><topic>Human monkeypox</topic><topic>Massachusetts</topic><topic>Smallpox vaccine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Matias, Wilfredo R</creatorcontrib><creatorcontrib>Koshy, Jacob M</creatorcontrib><creatorcontrib>Nagami, Ellen H</creatorcontrib><creatorcontrib>Kovac, Victor</creatorcontrib><creatorcontrib>Moeng, Letumile R</creatorcontrib><creatorcontrib>Shenoy, Erica S</creatorcontrib><creatorcontrib>Hooper, David C</creatorcontrib><creatorcontrib>Madoff, Lawrence C</creatorcontrib><creatorcontrib>Barshak, Miriam B</creatorcontrib><creatorcontrib>Johnson, Jennifer A</creatorcontrib><creatorcontrib>Rowley, Christopher F</creatorcontrib><creatorcontrib>Julg, Boris</creatorcontrib><creatorcontrib>Hohmann, Elizabeth L</creatorcontrib><creatorcontrib>Lazarus, Jacob E</creatorcontrib><collection>Oxford Journals Open Access Collection</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale Academic OneFile</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Open Forum Infectious Diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Matias, Wilfredo R</au><au>Koshy, Jacob M</au><au>Nagami, Ellen H</au><au>Kovac, Victor</au><au>Moeng, Letumile R</au><au>Shenoy, Erica S</au><au>Hooper, David C</au><au>Madoff, Lawrence C</au><au>Barshak, Miriam B</au><au>Johnson, Jennifer A</au><au>Rowley, Christopher F</au><au>Julg, Boris</au><au>Hohmann, Elizabeth L</au><au>Lazarus, Jacob E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Tecovirimat for the Treatment of Human Monkeypox: An Initial Series From Massachusetts, United States</atitle><jtitle>Open Forum Infectious Diseases</jtitle><addtitle>Open Forum Infect Dis</addtitle><date>2022-08-01</date><risdate>2022</risdate><volume>9</volume><issue>8</issue><spage>ofac377</spage><epage>ofac377</epage><pages>ofac377-ofac377</pages><issn>2328-8957</issn><eissn>2328-8957</eissn><abstract>Abstract A large, ongoing multicountry outbreak of human monkeypox has the potential to cause considerable morbidity and mortality. Therapeutics for the treatment of smallpox, a related Orthopoxvirus, may be used and affect the natural history of monkeypox. We present 3 patients from our hospitals treated with tecovirimat, a pan-Orthopoxvirus inhibitor currently available under an expanded access investigational new drug protocol for monkeypox.</abstract><cop>United States</cop><pub>Oxford University Press</pub><pmid>35949403</pmid><doi>10.1093/ofid/ofac377</doi><orcidid>https://orcid.org/0000-0001-8086-1123</orcidid><orcidid>https://orcid.org/0000-0002-4687-9626</orcidid><orcidid>https://orcid.org/0000-0001-9286-3548</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2328-8957
ispartof Open Forum Infectious Diseases, 2022-08, Vol.9 (8), p.ofac377-ofac377
issn 2328-8957
2328-8957
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9356679
source Oxford Journals Open Access Collection; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central
subjects Brief Report
Care and treatment
Health aspects
Hospitals
Human monkeypox
Massachusetts
Smallpox vaccine
title Tecovirimat for the Treatment of Human Monkeypox: An Initial Series From Massachusetts, United States
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T18%3A00%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Tecovirimat%20for%20the%20Treatment%20of%20Human%20Monkeypox:%20An%20Initial%20Series%20From%20Massachusetts,%20United%20States&rft.jtitle=Open%20Forum%20Infectious%20Diseases&rft.au=Matias,%20Wilfredo%20R&rft.date=2022-08-01&rft.volume=9&rft.issue=8&rft.spage=ofac377&rft.epage=ofac377&rft.pages=ofac377-ofac377&rft.issn=2328-8957&rft.eissn=2328-8957&rft_id=info:doi/10.1093/ofid/ofac377&rft_dat=%3Cgale_pubme%3EA776147225%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2701074162&rft_id=info:pmid/35949403&rft_galeid=A776147225&rft_oup_id=10.1093/ofid/ofac377&rfr_iscdi=true